Table 1.

Clinical Characteristics and Drug Treatment of Patients With Obsessive-Compulsive Disorder Who Received Active or Sham Repetitive Transcranial Magnetic Stimulation (rTMS)

	Pharmacologic Treatment	BaselineYBOCS Score	YBOCS ScoreAfter rTMS	YBOCS Score After rTMS (12-wk follow-up)
Group and Patients				2wk	4 wk	6 wk	8 wk	10 wk	12 wk
Active rTMS
1	Fluvoxamine	36	34	34	34	33	33	33	33
2	Venlafaxine, risperidone	26	18	19	22	19	19	19	19
3	Fluvoxamine	25	15	15	15	15	15	15	15
4	Fluvoxamine	32	30	30	30	30	30	30	30
5	Fluoxetine	37	24	27	29	27	25	25	25
6	Fluvoxamine, paroxetine	28	17	17	17	17	17	16	16
7	Fluvoxamine, clomipramine, risperidone	31	21	21	21	21	21	21	21
8	Clomipramine	34	34	34	34	34	34	34	34
9	Fluvoxamine	31	28	28	28	28	28	28	28
10	Clomipramine	39	36	35	40	40	40	39	39
11	Sertraline	16	10	6	6	6	6	6	6
12	Clomipramine, risperidone	34	25	25	25	25	25	30	30
13	Fluvoxamine	38	33	33	33	34	34	34	34
14	Clomipramine	36	24	12	12	12	20	28	36
15	Fluvoxamine	38	36	36	36	36	36	36	36
16	Fluvoxamine	34	33	33	34	34	34	34	34
Sham rTMS
17	Venlafaxine	26	26	26	26	26	26	26	26
18	Fluvoxamine, clomipramine	22	22	22	22	22	22	22	22
19	Clomipramine	28	28	28	28	28	28	28	28
20	Clomipramine, risperidone	37	37	37	37	37	37	37	37
21	Clomipramine	29	24	24	29	24	24	29	24
22	Fluvoxamine	40	40	40	40	40	40	40	40
23	Fluoxetine	38	28	28	30	30	28	30	30

Abbreviation: YBOCS = Yale-Brown Obsessive Compulsive Scale.